Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 9 Polycystic Ovary Syndrome 8 Multiple Myeloma 4 Melanoma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Skin Neoplasms 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Diabetes Mellitus 2

Interventions

Cyclophosphamide 32 Temozolomide 30 Filgrastim 24 Carboplatin 23 Etoposide 22 Vincristine 18 Radiotherapy 18 Cisplatin 18 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 12 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Lomustine 9 Topotecan 8 Specimen Handling 8 Methotrexate 8 etoposide phosphate 7 Radiation 7 X-Rays 6 Phantoms, Imaging 6 Biopsy 6 sonidegib 5 sargramostim 5 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡